Tech Company Financing Transactions

KGK Science Funding Round

On 7/27/2026, KGK Science raised funding from Maxim Group and private investors.

Transaction Overview

Company Name
Announced On
7/27/2026
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors

Maxim Group (Lead Investor)

Proceeds Purpose
The company intends to use the funds to support expanded clinical trial capacity, continued investment in decentralized and virtual trial capabilities, growth of its regulatory services, and continued expansion of its commercial organization.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
275 Dundas St. G02
London, ON, N6B 3L1
Canada
Phone
Undisclosed
Email Address
Overview
KGK Science has played a key role in the natural health product industry by providing our clients with high-quality clinical research and regulatory expertise to bring safe and effective products to global markets. As a full-service premium contract research organization (CRO) supporting the nutraceutical industry, KGK is one of the most reliable resources for brands looking for an experienced, trustworthy team of scientific researchers, consultants, and regulatory specialists to develop customized claim substantiation and path-to-market strategies.
Profile
KGK Science LinkedIn Company Profile
Social Media
KGK Science Company Twitter Account
Company News
KGK Science News
Facebook
KGK Science on Facebook
YouTube
KGK Science on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Najla Guthrie
  Najla Guthrie LinkedIn Profile  Najla Guthrie Twitter Account  Najla Guthrie News  Najla Guthrie on Facebook
Chief Financial Officer
David Garland
  David Garland LinkedIn Profile  David Garland Twitter Account  David Garland News  David Garland on Facebook
Chief Scientific Officer
Erin Lewis
  Erin Lewis LinkedIn Profile  Erin Lewis Twitter Account  Erin Lewis News  Erin Lewis on Facebook
VP - Client Services
Marc Moulin
  Marc Moulin LinkedIn Profile  Marc Moulin Twitter Account  Marc Moulin News  Marc Moulin on Facebook
VP - Operations
Nisrine Zakaria
  Nisrine Zakaria LinkedIn Profile  Nisrine Zakaria Twitter Account  Nisrine Zakaria News  Nisrine Zakaria on Facebook
VP - Regulatory Affairs
Andrew Charrette
  Andrew Charrette LinkedIn Profile  Andrew Charrette Twitter Account  Andrew Charrette News  Andrew Charrette on Facebook
VP - Regulatory Affairs
Corey Hilmas
  Corey Hilmas LinkedIn Profile  Corey Hilmas Twitter Account  Corey Hilmas News  Corey Hilmas on Facebook
VP - Sales
Bibiane Zakaria
  Bibiane Zakaria LinkedIn Profile  Bibiane Zakaria Twitter Account  Bibiane Zakaria News  Bibiane Zakaria on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/27/2026: Fly.io venture capital transaction
Next: 7/27/2026: Nuclear Turbines venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary